STATE TRADING
QUESTION POSED BY THE EUROPEAN UNION REGARDING
THE NEW AND FULL NOTIFICATION OF TUNISIA[1]
The following communication, dated 25 October 2016, is
being circulated at the request of the Delegation of the European Union.
_______________
Question
The EU
welcomes the detailed notification submitted by Tunisia and acknowledges the
efforts done for its preparation. We would like to note our concern on the
Pharmacie Centrale de Tunisie, which detains the monopoly for the importations
of medicines. First, since May 2013 exporters are forced to accept to take
charge of the dinar depreciation over the next 4 years, in order to sell any
new pharmaceutical product. Then, as stated in the notification, the price
of the medicines is subject to the approval of the Minister responsible for
trade and the margins for each distribution level are set by the State.
Consequently, the public prices are standardized and identical throughout the
country. The EU also notes that the notification does not contain the relevant
statistics.
The EU
would like to invite Tunisia to submit detailed information on the criteria
used by the public authorities to define the margins for each distribution
level as well as the missing statistical information.
__________
[1] G/STR/N/15/TUN-G/STR/N/16/TUN (dated 8 June
2016).